Companies: 10,795·Total market cap: $144.5T
BioLife Solutions, Inc.

BioLife Solutions, Inc.

BLFSNASDAQHealthcare● Active
$26.64
$-0.01(-0.04%)
Market Cap$1.3B
P/E Ratio
52W High$29.62
52W Low$17.86
Overview

BioLife Solutions, Inc.(BLFS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BLFS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$96.21M$82.25M$75.86M$76.24M$119.16M
Cost of Revenue$34.10M$28.58M$96.52M$29.33M$90.31M
Gross Profit$62.12M$53.67M$46.75M$46.91M$28.85M
Gross Margin %(computed)64.56%65.25%61.63%61.53%24.21%
Operating Expenses
R&D Expenses$7.57M$7.91M$18.80M$14.80M$11.82M
G&A Expenses$45.52M$40.54M$43.26M$33.26M$34.10M
Total Operating Expenses$74.25M$60.80M$117.58M$52.83M$73.34M
Operating Income($12.13M)($7.13M)($23.44M)($5.92M)($35.16M)
Operating Margin %(computed)-12.61%-8.67%-30.90%-7.77%-29.51%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$2.71M$0.72M$1.81M$0.69M$0.48M
Income Before Tax($12.08M)($11.43M)($18.47M)($4.85M)($29.03M)
Income Tax Expense$0.05M($0.04M)$0.02M($5.24M)($20.12M)
Net Income($12.13M)($20.18M)($66.43M)($139.81M)($8.91M)
Net Margin %(computed)-12.61%-24.54%-87.57%-183.38%-7.48%
Per Share & EBITDA
EPS (Basic)$-0.25$-0.44$-1.52$-3.29$-0.23
Wtd Avg Shares47.75M46.07M43.72M42.48M38.50M
EBITDA($9.38M)$1.53M($45.24M)($124.18M)($16.65M)
EBITDA Margin %(computed)-9.74%1.86%-59.64%-162.89%-13.98%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解BioLife Solutions, Inc.

关于BioLife Solutions, Inc.(BLFS)损益表

BioLife Solutions, Inc.(BLFS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BLFS实现营收$0.10B,毛利润$0.06B(毛利率64.56%),净利润($0.01B)(净利率-12.61%)。

常见问题

BLFS · 4 问

BioLife Solutions, Inc.(BLFS)2025财年营收为$0.10B,同比up17.0%。

BLFS revenueBLFS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08